CLINICAL MYAMATOSIS AND ITS REPERCUSSIONS LITERATURE REVIEW

• Autor(a) principal: Borchardt, Poliane Reis Targino
• Data de Publicação: 2024
• Outros Autores: Ferreira , Diego Pariasca, Lopes , Vanessa de Morais, Tavares , Cláudia karoline de Souza, Silva, Letícia Clemente da, Vitorino , Helen Regina Santos, Afiune, Gabriela Barros, Corrêa, Carine Flecha, Pereira , José, Benetti , Nicolas Guilherme patel, Cardoso , Fernanda Vieira, Nascimento , Thiago Ruam
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/1762
• topic: Histerectomia; Miamatose; Miomectomia Uterina; Casos Clínicos.; Hysterectomy; Miamatosis; Uterine Myomectomy; Clinical cases.

Uterine leiomyoma, known as myoma, is a benign tumor that affects a significant proportion of women of reproductive age. Its high incidence, which can reach 40%, makes this condition a relevant medical and social challenge. Its origin is related to the clonal expansion of a single cell in the uterine myometrium, although the exact pathogenetic mechanisms are not yet fully understood. This study presents an integrative analysis with the aim of discussing the possibilities of clinical and surgical treatment for uterine fibroids, addressing aspects of the pathology to contribute to the knowledge of society, students and professionals in the field. The research was carried out in databases and there is no proof of the effectiveness of oral contraceptives in the treatment of fibroids. However, they are useful in controlling dysfunctional uterine bleeding. Definitive treatment for symptomatic fibroids is usually surgical, with hysterectomy being one of the main options. In summary, uterine fibroids are common and can significantly impact women's quality of life. Medical and surgical treatment options offer diverse therapeutic approaches, each with specific advantages and considerations.